Bayesian Estimation of Vancomycin Exposure and Population Pharmacokinetics in Obese Patients
Antibiotics · 11.05.2026 · 15 (5) · 485
DOI: 10.3390/antibiotics15050485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 11.05.2026. Verfasst von Ha-Jin Chun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Ajou University Hospital, Suwon 16499, Republic of Korea. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gyeonggi Research Institute, GRRC Program of Gyeonggi Province.
Abstract (Originalsprache)
Background/Objectives: This study compared the pharmacokinetic (PK)/pharmacodynamic (PD) targets of vancomycin in obese patients using two Bayesian programs to evaluate the accuracy and bias of these estimates. Additionally, population pharmacokinetics in obese patients were compared with those in the general patient population.
Methods
Medical records of obese adults [body mass index (BMI) ≥ 30 kg/m2] treated with vancomycin at Ajou University Hospital between 2010 and 2017 were retrospectively reviewed. Patients with peak (Cpeak) and trough (Ctrough) concentrations were included. Vancomycin area under the plasma concentration-time curve (AUC) and Ctrough were estimated using Capcil (ver 6.31) and MwPharm (ver 2.3.1.89) software. Accuracy and bias were analyzed, and population PK parameters were evaluated.
Results
A total of 149 cases were analyzed. AUC estimates from one-point sampling using Capcil were significantly lower than the reference values, whereas MwPharm produced estimates closer to the reference with higher accuracy and lower bias. Ctrough estimates from one-point sampling showed high accuracy for both programs. Obese patients exhibit lower volume of distribution, higher total body clearance, and shorter elimination half-life than the general patient population.
Conclusions
Vancomycin pharmacokinetics differ in obese patients. Bayesian analysis using MwPharm showed AUC and Ctrough estimates that were closer to the reference values and exhibited lower bias than those obtained with Capcil in this dataset. These findings may support more informed dosing decisions for vancomycin in obese patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Ajou University Hospital, Suwon 16499, Republic of Korea.
- College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea.
- Research Institute of Pharmaceutical Science and Technology, Ajou University, Suwon 16499, Republic of Korea.
- Department of Diagnostic & Biomedical Sciences, School of Dentistry, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA.
- Department of Infectious Diseases, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
- Department of Biohealth Regulatory Science, Graduate School of Ajou University, Suwon 16499, Republic of Korea.
ORCID-Profile: Ha-Jin Chun, So Hee Kim
Förderung
- Gyeonggi Research Institute
- GRRC Program of Gyeonggi Province
Zitieren
APA
Chun, H. J., Choi, H. G., Bang, E. S., Kyun, J. O., Kim, Y. R., Kim, E. J., & Kim, S. H. (2026). Bayesian Estimation of Vancomycin Exposure and Population Pharmacokinetics in Obese Patients. Antibiotics, 15(5), 485. https://doi.org/10.3390/antibiotics15050485
Vancouver
Chun HJ, Choi HG, Bang ES, Kyun JO, Kim YR, Kim EJ, et al. Bayesian Estimation of Vancomycin Exposure and Population Pharmacokinetics in Obese Patients. Antibiotics. 2026;15(5):485. doi:10.3390/antibiotics15050485
BibTeX
@article{Chun2026,
author = {Chun, Ha-Jin and Choi, Hyeon Gyeom and Bang, Eun Sook and Kyun, Jin Ok and Kim, Young Rong and Kim, Eun Jin and Kim, So Hee},
title = {Bayesian Estimation of Vancomycin Exposure and Population Pharmacokinetics in Obese Patients},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {5},
pages = {485},
doi = {10.3390/antibiotics15050485}
}
EUVIMED